Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML)

Also known as: Philadelphia Positive Chronic Myeloid Leukemia / Chronic Myeloid Leukemia, BCR/ABL-Positive / Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Chronic Myelogenous Leukemia, BCR-ABL Positive / Chronic Myelogenous Leukemia, BCR/ABL Positive / Philadelphia Chromosome Positive Chronic Myelogenous Leukemia / BCR-ABL Positive Chronic Myelogenous Leukemia / CML - Philadelphia Chromosome / Philadelphia Chromosome Positive CML / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Philadelphia Positive (Ph+) Chronic Myeloid Leukemia / Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia / Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive / BCR-ABL1 Positive Chronic Myelogenous Leukemia / Leukemia, Myeloid, Chronic, BCR-ABL Positive / Philadelphia Chromosome-Positive Chronic Myeloid Leukemia / Ph1 Positive CML / Chronic Myeloid Leukemia (CML) With Philadelphia Chromosome-positive (Ph+) / Leukemia,Myeloid,Philadelphia-Positive / Leukemia, Myeloid, Philadelphia-Positive / Myeloid Leukemia, Philadelphia Positive / Philadelphia-Positive Myeloid Leukemia / Philadelphia positive chronic myeloid leukaemia

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00928	Azacitidine	1	Completed	1
DB05015	Belinostat	1	Completed	1
DB06616	Bosutinib	1	Completed	1
DB00091	Cyclosporine	1	Terminated	1
DB00987	Cytarabine	1	Completed	1
DB01254	Dasatinib	1	Completed	1
DB01254	Dasatinib	1	Terminated	2
DB14598	Edetate calcium disodium anhydrous	1	Recruiting	1
DB00974	Edetic acid	1	Recruiting	1
DB00619	Imatinib	1	Completed	1
DB00619	Imatinib	1	Terminated	2
DB06186	Ipilimumab	1	Completed	1
DB14123	Menthol	1	Terminated	1
DB04868	Nilotinib	1	Completed	1
DB04868	Nilotinib	1	Terminated	1
DB17320	Prexigebersen	1	Completed	1
DB08877	Ruxolitinib	1	Terminated	1
DB09143	Sonidegib	1	Completed	1
DB00566	Succimer	1	Recruiting	1
DB06287	Temsirolimus	1	Terminated	1
DB17459	Therapeutic allogeneic lymphocytes	1	Completed	1
DB12597	Asciminib	1 / 2	Recruiting	1
DB06616	Bosutinib	1 / 2	Active Not Recruiting	1
DB00531	Cyclophosphamide	1 / 2	Recruiting	1
DB00987	Cytarabine	1 / 2	Completed	1
DB01073	Fludarabine	1 / 2	Recruiting	1
DB01005	Hydroxyurea	1 / 2	Completed	1
DB00619	Imatinib	1 / 2	Completed	3
DB11997	Interleukin-7	1 / 2	Completed	1
DB04868	Nilotinib	1 / 2	Completed	1
DB12323	Radotinib	1 / 2	Completed	1
DB00398	Sorafenib	1 / 2	Completed	1
DB04960	Tipifarnib	1 / 2	Completed	1
DB15396	Vamotinib	1 / 2	Unknown Status	1
DB01955	1,4-Butanediol	2	Completed	1
DB02594	2'-Deoxycytidine	2	Completed	1
DB09312	Antilymphocyte immunoglobulin (horse)	2	Completed	1
DB09312	Antilymphocyte immunoglobulin (horse)	2	Terminated	1
DB00098	Antithymocyte immunoglobulin (rabbit)	2	Completed	1
DB00098	Antithymocyte immunoglobulin (rabbit)	2	Terminated	1
DB00112	Bevacizumab	2	Terminated	1
DB00188	Bortezomib	2	Terminated	1
DB16741	Bortezomib D-mannitol	2	Terminated	1
DB06616	Bosutinib	2	Active Not Recruiting	1
DB01008	Busulfan	2	Active Not Recruiting	1
DB01008	Busulfan	2	Completed	2
DB15694	Cedazuridine	2	Recruiting	1
DB00631	Clofarabine	2	Completed	1
DB06189	Clofarabine	2	Completed	1
DB09110	Coenzyme M	2	Withdrawn	1
DB00531	Cyclophosphamide	2	Active Not Recruiting	3
DB00531	Cyclophosphamide	2	Completed	2
DB00531	Cyclophosphamide	2	Recruiting	2
DB00531	Cyclophosphamide	2	Withdrawn	1
DB00091	Cyclosporine	2	Active Not Recruiting	1
DB00091	Cyclosporine	2	Completed	5
DB00987	Cytarabine	2	Completed	1
DB00987	Cytarabine	2	Terminated	1
DB00987	Cytarabine	2	Withdrawn	1
DB01254	Dasatinib	2	Active Not Recruiting	1
DB01254	Dasatinib	2	Completed	4
DB01254	Dasatinib	2	Recruiting	1
DB01262	Decitabine	2	Completed	1
DB01262	Decitabine	2	Recruiting	1
DB01234	Dexamethasone	2	Withdrawn	1
DB00997	Doxorubicin	2	Withdrawn	1
DB00099	Filgrastim	2	Completed	1
DB15223	Flotetuzumab	2	Withdrawn	1
DB01073	Fludarabine	2	Active Not Recruiting	3
DB01073	Fludarabine	2	Completed	6
DB01073	Fludarabine	2	Recruiting	2
DB09053	Ibrutinib	2	Completed	1
DB01177	Idarubicin	2	Terminated	1
DB00619	Imatinib	2	Active Not Recruiting	2
DB00619	Imatinib	2	Completed	9
DB00619	Imatinib	2	Unknown Status	3
DB00105	Interferon alfa-2b	2	Terminated	1
DB00650	Leucovorin	2	Withdrawn	1
DB00888	Mechlorethamine	2	Completed	1
DB01042	Melphalan	2	Active Not Recruiting	1
DB16620	Methopterin	2	Completed	1
DB00563	Methotrexate	2	Completed	2
DB00563	Methotrexate	2	Withdrawn	1
DB00688	Mycophenolate mofetil	2	Active Not Recruiting	2
DB00688	Mycophenolate mofetil	2	Completed	6
DB04868	Nilotinib	2	Active Not Recruiting	1
DB04868	Nilotinib	2	Completed	3
DB04868	Nilotinib	2	Withdrawn	1
DB04865	Omacetaxine mepesuccinate	2	Completed	2
DB00022	Peginterferon alfa-2b	2	Terminated	1
DB00552	Pentostatin	2	Completed	1
DB01132	Pioglitazone	2	Completed	1
DB01132	Pioglitazone	2	Terminated	1
DB01132	Pioglitazone	2	Unknown Status	1
DB08901	Ponatinib	2	Active Not Recruiting	1
DB00635	Prednisone	2	Withdrawn	1
DB00073	Rituximab	2	Completed	1
DB00073	Rituximab	2	Withdrawn	1
DB14546	Sulfate ion	2	Withdrawn	1
DB00864	Tacrolimus	2	Active Not Recruiting	1
DB00864	Tacrolimus	2	Completed	4
DB00864	Tacrolimus	2	Terminated	1
DB17459	Therapeutic allogeneic lymphocytes	2	Completed	4
DB04572	Thiotepa	2	Active Not Recruiting	1
DB04572	Thiotepa	2	Completed	1
DB04572	Thiotepa	2	Recruiting	2
DB11678	Treosulfan	2	Completed	1
DB03754	Tromethamine	2	Completed	1
DB00135	Tyrosine	2	Terminated	1
DB00135	Tyrosine	2	Unknown Status	1
DB00541	Vincristine	2	Withdrawn	1
DB02546	Vorinostat	2	Completed	1
DB12597	Asciminib	3	Active Not Recruiting	1
DB12597	Asciminib	3	Recruiting	2
DB06616	Bosutinib	3	Active Not Recruiting	1
DB01254	Dasatinib	3	Active Not Recruiting	1
DB00619	Imatinib	3	Active Not Recruiting	1
DB00619	Imatinib	3	Completed	2
DB00619	Imatinib	3	Recruiting	1
DB00619	Imatinib	3	Unknown Status	1
DB04868	Nilotinib	3	Active Not Recruiting	1
DB04868	Nilotinib	3	Completed	1
DB04868	Nilotinib	3	Recruiting	1
DB04868	Nilotinib	3	Terminated	1
DB12323	Radotinib	3	Completed	1
DB12323	Radotinib	3	Recruiting	1
DB12597	Asciminib	4	Recruiting	1
DB06616	Bosutinib	4	Recruiting	1
DB01254	Dasatinib	4	Recruiting	1
DB00619	Imatinib	4	Recruiting	1
DB04868	Nilotinib	4	Recruiting	1
DB06616	Bosutinib	Not Available	Completed	1
DB01254	Dasatinib	Not Available	Completed	2
DB01254	Dasatinib	Not Available	Withdrawn	1
DB00619	Imatinib	Not Available	Completed	1
DB00619	Imatinib	Not Available	Withdrawn	1
DB04868	Nilotinib	Not Available	Completed	1
DB04868	Nilotinib	Not Available	Withdrawn	1
DB12323	Radotinib	Not Available	Withdrawn	1